Preventive Vaccines - Global Market Outlook (2018-2027)

   |      |      |  

Preventive Vaccines - Global Market Outlook (2018-2027)

"The Global Preventive Vaccines market is accounted for $40.80 billion in 2018 and is expected to reach $94.64 billion by 2027 growing at a CAGR of 9.8% during the forecast period. Some of the key factors propelling the market growth include increased funding from government and international organizations, growing prevalence of infectious diseases, rise in investments, initiatives by NGO’s, and innovative technology in vaccine development. However, high cost of vaccine development is restraining the market growth.

Preventative vaccine is administered to a person who is free of the targeted infection, in order to support the body’s immune system against future infections. These vaccines consist of attenuated or killed microbes, or microbial DNA. When administered, the immune system triggers a response that produces antibodies. Various infectious diseases are considered to be the world’s leading causes of death. Scientists of various countries are performing various researches, building laboratories in underdeveloped countries, sharing information, and creating surveillance networks globally in order to control the disease spread through preventive vaccination.

By vaccine type, live/attenuated vaccines contain weakened versions of living microbes, making them ineffective to cause diseases. These vaccines produce a similar, yet weakened reaction, compared to that of natural infections. These vaccines need to be refrigerated to stay potent. In addition, Live/attenuated vaccines for certain viruses are relatively easy to create. Vaccines against measles, mumps, and chickenpox, among others, are designed using this method. Pertaining to the ease of manufacturing, and the ability to generate strong immune responses to the market for live/attenuated vaccines, a steady growth rate is expected during the forecast period.

On the basis of geography, North America is expected to have considerable market growth during the forecast period. In the United States, the Centers for Disease Control and Prevention's (CDC) Advisory Committee for Immunization Practices (ACIP) routinely publishes recommendations for adult and childhood vaccination. The United States has one of the leading healthcare systems in the world and the vaccination coverage, in terms of vaccine inclusion, is at par with the WHO guidelines.

Some of the key players in preventive vaccines market include AstraZeneca PLC, Johnson & Johnson, CSL Limited, Bavarian Nordic, GlaxoSmithKline PLC, MedImmune LLC, Merck and Company, Sanofi Pasteur, Takeda Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Co. Ltd., Emergent BioSolutions, Inc., Novartis AG, and Pfizer, Inc.

Disease Types Covered:
• Influenza
• Measles, Mumps, and Rubella (MMR)
• Poliovirus
• Hepatitis
• Pneumococcal
• HIB
• Varicella
• Zoster
• Cervical Cancer
• Human Papilloma Virus

Vaccine Types Covered:
• Toxoid Vaccines
• Subunit Vaccines
• Inactivated Vaccines
• Live/Attenuated Vaccines
• DNA Vaccines
• Conjugate Vaccines
• Recombinant Vector Vaccines

End Users Covered:
• Adult Vaccines
• Pediatric Vaccines

Product Types Covered:
• Nasal Spray
• Intramuscular Injection
• Intradermal Shot

Applications Covered:
• Clinic
• Hospital

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
"

"1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Product Analysis
3.8 Application Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Preventive Vaccines Market, By Disease Type
5.1 Introduction
5.2 Influenza
5.3 Measles, Mumps, and Rubella (MMR)
5.4 Poliovirus
5.5 Hepatitis
5.6 Pneumococcal
5.7 HIB
5.8 Varicella
5.9 Zoster
5.10 Cervical Cancer
5.11 Human Papilloma Virus

6 Global Preventive Vaccines Market, By Vaccine Type
6.1 Introduction
6.2 Toxoid Vaccines
6.3 Subunit Vaccines
6.4 Inactivated Vaccines
6.5 Live\/Attenuated Vaccines
6.6 DNA Vaccines
6.7 Conjugate Vaccines
6.8 Recombinant Vector Vaccines

7 Global Preventive Vaccines Market, By End User
7.1 Introduction
7.2 Adult Vaccines
7.3 Pediatric Vaccines

8 Global Preventive Vaccines Market, By Product Type
8.1 Introduction
8.2 Nasal Spray
8.3 Intramuscular Injection
8.4 Intradermal Shot

9 Global Preventive Vaccines Market, By Application
9.1 Introduction
9.2 Clinic
9.3 Hospital

10 Global Preventive Vaccines Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 AstraZeneca PLC
12.2 Johnson & Johnson
12.3 CSL Limited
12.4 Bavarian Nordic
12.5 GlaxoSmithKline PLC
12.6 MedImmune LLC
12.7 Merck and Company
12.8 Sanofi Pasteur
12.9 Takeda Pharmaceutical Co. Ltd.
12.10 Mitsubishi Tanabe Pharma Corporation
12.11 Daiichi Sankyo Co. Ltd.
12.12 Emergent BioSolutions, Inc.
12.13 Novartis AG
12.14 Pfizer, Inc

List of Tables
Table 1 Global Preventive Vaccines Market Outlook, By Region (2017-2027) ($MN)
Table 2 Global Preventive Vaccines Market Outlook, By Disease Type (2017-2027) ($MN)
Table 3 Global Preventive Vaccines Market Outlook, By Influenza (2017-2027) ($MN)
Table 4 Global Preventive Vaccines Market Outlook, By Measles, Mumps, and Rubella (MMR) (2017-2027) ($MN)
Table 5 Global Preventive Vaccines Market Outlook, By Poliovirus (2017-2027) ($MN)
Table 6 Global Preventive Vaccines Market Outlook, By Hepatitis (2017-2027) ($MN)
Table 7 Global Preventive Vaccines Market Outlook, By Pneumococcal (2017-2027) ($MN)
Table 8 Global Preventive Vaccines Market Outlook, By HIB (2017-2027) ($MN)
Table 9 Global Preventive Vaccines Market Outlook, By Varicella (2017-2027) ($MN)
Table 10 Global Preventive Vaccines Market Outlook, By Zoster (2017-2027) ($MN)
Table 11 Global Preventive Vaccines Market Outlook, By Cervical Cancer (2017-2027) ($MN)
Table 12 Global Preventive Vaccines Market Outlook, By Human Papilloma Virus (2017-2027) ($MN)
Table 13 Global Preventive Vaccines Market Outlook, By Vaccine Type (2017-2027) ($MN)
Table 14 Global Preventive Vaccines Market Outlook, By Toxoid Vaccines (2017-2027) ($MN)
Table 15 Global Preventive Vaccines Market Outlook, By Subunit Vaccines (2017-2027) ($MN)
Table 16 Global Preventive Vaccines Market Outlook, By Inactivated Vaccines (2017-2027) ($MN)
Table 17 Global Preventive Vaccines Market Outlook, By Live\/Attenuated Vaccines (2017-2027) ($MN)
Table 18 Global Preventive Vaccines Market Outlook, By DNA Vaccines (2017-2027) ($MN)
Table 19 Global Preventive Vaccines Market Outlook, By Conjugate Vaccines (2017-2027) ($MN)
Table 20 Global Preventive Vaccines Market Outlook, By Recombinant Vector Vaccines (2017-2027) ($MN)
Table 21 Global Preventive Vaccines Market Outlook, By End User (2017-2027) ($MN)
Table 22 Global Preventive Vaccines Market Outlook, By Adult Vaccines (2017-2027) ($MN)
Table 23 Global Preventive Vaccines Market Outlook, By Pediatric Vaccines (2017-2027) ($MN)
Table 24 Global Preventive Vaccines Market Outlook, By Product Type (2017-2027) ($MN)
Table 25 Global Preventive Vaccines Market Outlook, By Nasal Spray (2017-2027) ($MN)
Table 26 Global Preventive Vaccines Market Outlook, By Intramuscular Injection (2017-2027) ($MN)
Table 27 Global Preventive Vaccines Market Outlook, By Intradermal Shot (2017-2027) ($MN)
Table 28 Global Preventive Vaccines Market Outlook, By Application (2017-2027) ($MN)
Table 29 Global Preventive Vaccines Market Outlook, By Clinic (2017-2027) ($MN)
Table 30 Global Preventive Vaccines Market Outlook, By Hospital (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
"

Preventive Vaccines - Global Market Outlook (2018-2027)

.